IGF1 and Alzheimer disease: It has been postulated that these discrepancies can be explained in terms of resistance to IGF-I action early in AD development (reflected as increased serum IGF-I), followed by IGF-I deficiency when the disease progresses (reflected as lower serum IGF-I) (156).